Middle East & Africa Bioprocessing Market
The Middle East & Africa Bioprocessing Market size was valued at US$ 314.37 Mn in 2023 and is projected to reach US$ 725.54 Mn by 2031, growing at a CAGR of 11.0% during 2023 - 2031.
Report Coverage
- Product: Instruments and Consumables & Accessories
- Scale of Operation: Commercial Operations and Clinical Operations
- Application: Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy
- End User: Biopharmaceutical Companies, Contract Manufacturing Organization
US$ 314.37 Mn
Market size in 2023
US$ 725.54 Mn
Market Size by 2031
11.0%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Bioprocessing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Bioprocessing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Bioprocessing Market Regional Analysis
6.2 Middle East & Africa Bioprocessing Market Revenue 2021-2031 (US$ Million)
6.3 Middle East & Africa Bioprocessing Market Forecast Analysis
7. Middle East & Africa Bioprocessing Market Analysis – by Product
7.1 Instruments and Consumables & Accessories
- 7.1.1 Overview
- 7.1.2 Instruments and Consumables & Accessories: Middle East & Africa Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Middle East & Africa Bioprocessing Market Analysis – by Scale of Operation
8.1 Commercial Operations and Clinical Operations
- 8.1.1 Overview
- 8.1.2 Commercial Operations and Clinical Operations: Middle East & Africa Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Middle East & Africa Bioprocessing Market Analysis – by Application
9.1 Monoclonal Antibodies
- 9.1.1 Overview
- 9.1.2 Monoclonal Antibodies: Middle East & Africa Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Vaccines
- 9.2.1 Overview
- 9.2.2 Vaccines: Middle East & Africa Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Recombinant Protein
- 9.3.1 Overview
- 9.3.2 Recombinant Protein: Middle East & Africa Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Cell & Gene Therapy
- 9.4.1 Overview
- 9.4.2 Cell & Gene Therapy: Middle East & Africa Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Middle East & Africa Bioprocessing Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East & Africa Bioprocessing Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Middle East & Africa Bioprocessing Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 South Africa: Middle East & Africa Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa Bioprocessing Market Breakdown, by Product
- 10.2.1.1.2 South Africa: Middle East & Africa Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.1.3 South Africa: Middle East & Africa Bioprocessing Market Breakdown, by Application
- 10.2.1.2 Saudi Arabia: Middle East & Africa Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa Bioprocessing Market Breakdown, by Product
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa Bioprocessing Market Breakdown, by Application
- 10.2.1.3 UAE: Middle East & Africa Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa Bioprocessing Market Breakdown, by Product
- 10.2.1.3.2 UAE: Middle East & Africa Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.3.3 UAE: Middle East & Africa Bioprocessing Market Breakdown, by Application
- 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Bioprocessing Market Breakdown, by Product
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Bioprocessing Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Getinge AB
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Sartorius AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Corning Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 3M Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Eppendorf SE
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Agilent Technologies Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Cytiva US LLC.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
